Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

HDT 321

Drug Profile

HDT 321

Alternative Names: HDT-321

Latest Information Update: 05 Feb 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator HDT Bio; University of Texas Medical Branch
  • Class RNA vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Research Crimean-Congo haemorrhagic fever virus infections

Most Recent Events

  • 05 Feb 2025 HDT Bio plans a phase I trial in Crimean-Congo haemorrhagic fever virus infections (Prevention) in USA (IM) (NCT06799013)
  • 05 Dec 2022 Early research in Crimean-Congo haemorrhagic fever virus infections (Prevention) in USA (Parenteral)
  • 01 Dec 2022 HDT Bio in collaboration with the University of Texas Medical Branch receives BARDA grant from the US government for HDT 321 development in Congo hemorrhagic fever virus infections

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top